Fundamental: fall in U.S. weekly jobless claims, dollar strength, rising interest rates, bitcoin alternative to gold. Technical: strong sell below 200 day and lack of support/trend levels.
This stock isn't "worth" $50 on a good day. Buyers will move on to the next big 'meme' investment and get bored with GME after it stalls out and fails to moon shoot again. The only demand level will be on technical dead cat bounces as there is no fundamental value support at these nose bleed levels. ps: If you made money on the way up, good job.
BABA is under 2020 log trend and is consolidating as downward pressure starts to wane. Looking for bulls to step-in and push BABA out of consolidation as MACD continues to swing back up.
Short time frame trade to come out of this technology selloff that's dragging the rest of the market down.
Tech (Apple in particular) has been seen as a safe haven from the lockdown recession; stretched price per share in AAPL is making historical fundamentals hard to justify even with everything the Fed is doing (PS and PE Ratios Charted). Technically overstretched as well and wouldn't be afraid to start to shorting here.
Small Caps which are more cyclical in nature are coming out of a squeeze pattern and looking very bullish.
Both TNX and TYX are still near all time lows as long-term treasury bonds continue to be in high demand from lockdown recession monetary stimulus. A moderate sell off in treasuries may cause a rapid unwinding from overcrowded positions and set up a downside reversion to the mean over the next month or two. The current price action is well above the 20 day moving...
Catching the Nasdaq very stretch outside the upper bollinger band. High probability trade we sell off the following day (7/7).
Very simple TA setup with a 4 hour chart on XLE breaking out of a downward wedge pattern. MACD divergence + crossover of signal along with Psar trigger.
Second wave coronavirus headline risk is creating a spike in market insurance premium. Sell the premium and short VXX via call credit spreads or put debit spreads.
High Valuation ROKU is breaking down from support below the 50 and now 100 day moving average. Target = 200 day moving average.
1-hour candle chart using the 20-period moving average as a breakdown/breakout trigger. The longer that the price action stays under the moving average the higher the probability of a continuation breakout pattern. CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious diseases (like sickle cell disease).
- Winning parabolic sar strategy for buy/sell signals since August. - Slow Stochastic breaking above 50. - Keep it simple, Buy the dips. - Phase one China/US trade developments provide bullish demand on EEM.
Let's see if Oil can stretch above the 200 day moving average. Weaker dollar and phase one trade deal progress are driving this higher.
This is a tutorial on how to use Price multiples. Portfolio managers will use basic valuation heuristics like price to sales or price to earnings to help time their blue-chip stock purchases/sales. So you will often find support/resistance in the historical price-multiple chart. Apple looks very overvalued here from this recent run up to a 1.16T market cap. What...
Forget the high valuation for a minute and that we are already near most analyst price targets for $ROKU... The CFO sold all 100% of his 95,789 shares yesterday (11/18) for about $ 15 million. Why would portfolio managers want to increase stakes in $ROKU when the executive in charge of maximizing shareholder value sells his own shares... Technical: Original and...
I see emerging markets and US small caps lagging with the rest of equity market. I would like to see emerging markets grind higher over the next two weeks to a new 52 week high. This recent dip looks like a technical sell off and we are at a low risk entry point to go higher.